Eight Roads
Coatue leads $25m Series C for China’s Kyligence
Coatue Management has led a $25 million Series C round for Chinese big data analytics and cloud services company Kyligence.
Japan VC: Positive energy
Japan’s quiet venture capital space is booming within its own borders. Signs of a stronger exit market and an exuberant influx of corporate involvement are encouraging themes, but they will play out slowly
Eight Roads leads $6.3m round for India pharma player
Ashish Life Science, an Indian producer of generic pharmaceuticals for the international veterinary market, has raised a INR450 million ($6.3 million) Series A round led by Eight Roads Ventures India.
Eight Roads invests $31m in Indian pharma player
Eight Roads Ventures, the proprietary investment arm of Fidelity International, has invested INR2.18 billion ($30.6 million) in Indian pharmaceutical manufacturer Caplin Point. Sister fund F-Prime Capital Ventures also participated.
Deal focus: Medbanks brings big data to China cancer care
Medbanks raises a $59 million Series C round to update the traditional information networks that make China’s growing oncology industry tick. Quality of management has proven a critical investment factor
Chinese cancer database provider Medbanks raises $59m
Beijing and Shanghai-based Medbanks, an information service provider specializing in cancer care, has raised RMB400 million ($59 million) in Series C funding led by CLP Fund.
Innovent Biologics gains on debut after $421m IPO
Chinese cancer drug developer Innovent Biologics, which has a number of PE backers, closed up on its Hong Kong trading debut, following a HK$3.3 billion ($421 million) IPO.
Nio Capital, Eight Roads lead Series A for Innovusion
Innovusion, a US-based developer of Lidar technology for autonomous vehicles, has raised a $30 million Series A round led by Eight Roads Ventures China and Nio Capital, a unit of Chinese electric vehicle maker Nio.
Eight Roads leads Series C for India's PharmEasy
Indian online pharmacy PharmEasy has raised a $50 million Series C funding round led by Eight Roads Ventures, the proprietary investment arm of Fidelity International.
Japan Post backs $94m round for US-based Cloudian
Japan Post Investment Corporation (JPIC), a direct investment unit launched by Japan Post Bank and Japan Post Insurance earlier this year, has joined a $94 million round for Japan-founded and US-based data company Cloudian.
India's Shadowfax raises $22m Series C
Shadowfax, an Indian online-to-offline (O2O) logistics provider focused on hyperlocal delivery, has raised a $22 million Series C round led by Nokia Growth Partners (NGP).
China's Pony.ai adds $112m to Series A round
ClearVue Partners and Eight Roads Ventures have led a $112 million investment in China and US-based autonomous driving technology developer Pony.ai that brings the start-up’s total Series A funding to $214 million.
Eight Roads leads $15m Series B for China's Kyligence
Kyligence, a Chinese big data analytics business, has received $15 million in Series B funding led by Eight Roads, with participation from Cisco and several existing investors.
Cancer drug developer Innovent Biologics files for HK IPO
Innovent Biologics, a Chinese drug developer company with a number of PE backers, has filed for an IPO in Hong Kong under recently introduced rules allowing listings by biotech companies with no revenue or profits.
Hua Medicine files for HK IPO under biotech fastrack
Hua Medicine, a Chinese drug developer player that simultaneously closed its Series D and E funding rounds in March, has become the second company to file for a Hong Kong IPO under rules that allow zero revenue biotech businesses to go public.
ICOs: Normalizing the future
The application of virtual tokens as investment instruments is modernizing the venture capital industry. Stakeholders are discovering a range of pitfalls and possibilities during the transition
China VC specialization to accelerate as ecosystem expands
China’s venture capital ecosystem is set to see a rapid proliferation of niche sector funds as overall economic growth piques domestic competition in the asset class.
Eight Roads launches $275m China tech fund
Eight Roads Ventures, the proprietary investment arm of Fidelity International, has launched a China-focused technology fund worth $275 million. The parent company is the sole LP.
Paragon leads $20m round for India's Chai Point
Paragon Partners has led a $20 million Series C funding round for India-based Chai Point, a chai tea store operator that claims to be the country’s largest brand in its category.
VCs invest $25m in Japan's Plaid
Japanese digital marketing services provider Plaid has raised JPY1.5 billion ($25.1 million) from a group of VCs including existing investor Eight Roads Ventures Japan and Femto Partners.
Eight Roads India adds Goldman's Bhatia as partner
Eight Roads Ventures, the proprietary investment arm of Fidelity International, has added Shweta Bhatia, formerly of Goldman Sachs, as a partner in its India office.
China’s Hua Medicine gets $117m
Hua Medicine, a Chinese clinical-stage biotechnology company, has closed a combined Series D and Series E funding round at $117.4 million with support from a group of VCs.
Japanese online media player Candee gets $21.6m round
Eight Roads Japan has led a JPY2.45 billion ($21.6 million) funding round Tokyo-based online media start-up Candee.
Fund focus: Eight Roads fund targets Japan tech
Eight Roads Ventures has $223 million to deploy in Japan, with robotics, inbound tourism and healthcare all high on its agenda